← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Acadia Healthcare Company, Inc. (ACHC) 10-Year Financial Performance & Capital Metrics

ACHC • • Industrial / General
HealthcareHealthcare FacilitiesBehavioral & Mental Health ServicesBehavioral Health Facilities
AboutAcadia Healthcare Company, Inc. provides behavioral healthcare services in the United States and Puerto Rico. The company offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers, and outpatient clinics. As of March 31, 2022, it operated a network of 238 behavioral healthcare facilities with approximately 10,600 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.Show more
  • Revenue $3.15B +7.7%
  • EBITDA $672M +5.2%
  • Net Income $256M +1279.7%
  • EPS (Diluted) 2.78 +1258.3%
  • Gross Margin 22.57% -3.1%
  • EBITDA Margin 21.3% -2.4%
  • Operating Margin 16.56% -4.3%
  • Net Margin 8.1% +1195.5%
  • ROE 8.41% +1223.5%
  • ROIC 8.25% -6.3%
  • Debt/Equity 0.65 +24.9%
  • Interest Coverage 4.49 -27.2%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Strong 5Y profit CAGR of 18.6%
  • ✓Trading at only 0.3x book value

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 8 (bottom 8%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y12.12%
5Y9.45%
3Y10.87%
TTM4.58%

Profit (Net Income) CAGR

10Y11.9%
5Y18.6%
3Y10.27%
TTM-61.76%

EPS CAGR

10Y6.36%
5Y17.52%
3Y9.8%
TTM-61.64%

ROCE

10Y Avg9.56%
5Y Avg10.22%
3Y Avg10.74%
Latest10.6%

Peer Comparison

Behavioral Health Facilities
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
ACHCAcadia Healthcare Company, Inc.1.08B11.914.287.69%3.29%3.26%0.65

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+1.79B2.81B2.84B3.01B2.01B2.09B2.31B2.61B2.93B3.15B
Revenue Growth %0.79%0.57%0.01%0.06%-0.33%0.04%0.11%0.13%0.12%0.08%
Cost of Goods Sold+1.05B1.66B1.65B1.78B1.19B87.24M90.7M100.2M2.25B2.44B
COGS % of Revenue0.59%0.59%0.58%0.59%0.59%0.04%0.04%0.04%0.77%0.77%
Gross Profit+740.1M1.15B1.19B1.23B815.49M2B2.22B2.51B682.61M711.98M
Gross Margin %0.41%0.41%0.42%0.41%0.41%0.96%0.96%0.96%0.23%0.23%
Gross Profit Growth %0.94%0.56%0.03%0.04%-0.34%1.46%0.11%0.13%-0.73%0.04%
Operating Expenses+419.29M706.49M747.84M821.04M153.94M2B1.81B2.04B176.01M189.71M
OpEx % of Revenue0.23%0.25%0.26%0.27%0.08%0.96%0.78%0.78%0.06%0.06%
Selling, General & Admin148.99M258.83M273M307.71M153.94M1.31B1.42B1.6B176.01M189.71M
SG&A % of Revenue0.08%0.09%0.1%0.1%0.08%0.63%0.61%0.61%0.06%0.06%
Research & Development0000000000
R&D % of Revenue----------
Other Operating Expenses-36.57M-48.32M-24.27M-34.51M0690.32M390.16M445.6M00
Operating Income+320.81M445.14M437.88M412.74M661.55M0414.47M467.69M506.6M522.28M
Operating Margin %0.18%0.16%0.15%0.14%0.33%-0.18%0.18%0.17%0.17%
Operating Income Growth %0.86%0.39%-0.02%-0.06%0.6%-1%-0.13%0.08%0.03%
EBITDA+384.36M580.25M580.89M571.58M749.48M437.16M521.19M585.46M638.95M671.87M
EBITDA Margin %0.21%0.21%0.2%0.19%0.37%0.21%0.23%0.22%0.22%0.21%
EBITDA Growth %0.87%0.51%0%-0.02%0.31%-0.42%0.19%0.12%0.09%0.05%
D&A (Non-Cash Add-back)63.55M135.1M143.01M158.83M87.92M95.26M106.72M117.77M132.35M149.59M
EBIT320.81M445.14M437.88M251.93M314.09M341.9M352.75M443.9M56.77M458.25M
Net Interest Income+-106.74M-181.32M-176.01M-184.53M-187.32M-158.1M-76.99M-69.76M-82.13M-116.37M
Interest Income000876K000000
Interest Expense106.74M181.32M176.01M185.41M187.32M158.1M76.99M69.76M82.13M116.37M
Other Income/Expense-156.06M-412.19M-201.08M-581.7M-583.16M183.8M-138.71M-93.55M-531.96M-180.4M
Pretax Income+164.75M32.95M236.8M-168.95M78.39M183.8M275.76M374.14M-25.36M341.88M
Pretax Margin %0.09%0.01%0.08%-0.06%0.04%0.09%0.12%0.14%-0.01%0.11%
Income Tax+46.4M28.78M37.21M6.53M25.09M40.61M67.56M94.11M-9.7M77.39M
Effective Tax Rate %0.73%0.19%0.84%1.04%1.39%-3.66%0.69%0.73%0.85%0.75%
Net Income+119.55M6.14M199.84M-175.75M108.92M-672.13M190.63M273.14M-21.67M255.61M
Net Margin %0.07%0%0.07%-0.06%0.05%-0.32%0.08%0.1%-0.01%0.08%
Net Income Growth %0.44%-0.95%31.53%-1.88%1.62%-7.17%1.28%0.43%-1.08%12.8%
Net Income (Continuing)111.36M4.18M199.59M57.49M53.31M143.19M208.2M280.03M-15.66M264.48M
Discontinued Operations111K00056.81M-812.39M-12.64M000
Minority Interest8.05M17.75M22.42M28.81M0065.39M88.26M105.69M117.12M
EPS (Diluted)+1.750.072.30-2.011.24-7.652.102.98-0.242.78
EPS Growth %0.17%-0.96%31.86%-1.87%1.62%-7.17%1.27%0.42%-1.08%12.58%
EPS (Basic)1.750.072.30-2.011.24-7.652.153.05-0.242.79
Diluted Shares Outstanding68.39M85.97M87.06M87.29M87.82M88.59M90.79M91.56M90.95M92.06M
Basic Shares Outstanding68.08M85.7M86.95M87.29M87.61M87.88M88.77M89.68M90.95M91.62M
Dividend Payout Ratio----------

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+294.74M427.93M471.55M450.42M542.21M2.52B495.03M506.13M596M577.49M
Cash & Short-Term Investments11.21M57.06M67.29M50.51M99.53M378.7M133.81M97.65M100.07M76.31M
Cash Only11.21M57.06M67.29M50.51M99.53M378.7M133.81M97.65M100.07M76.31M
Short-Term Investments0000000000
Accounts Receivable239.43M314.77M344.97M318.09M321.06M297.08M304.45M353.74M429.53M421.98M
Days Sales Outstanding48.740.8744.3938.5458.3551.8848.0149.4653.5348.83
Inventory4.68M4.63M4.79M5.05M4.08M4.85M4.79M5.09M5.3M5.65M
Days Inventory Outstanding1.621.021.061.041.2520.319.2618.530.860.85
Other Current Assets40.4M75.45M75.23M45.96M90.19M1.81B17.69M10.6M25.01M32.2M
Total Non-Current Assets+3.99B5.6B5.95B5.72B6.34B3.98B4.27B4.48B4.76B5.38B
Property, Plant & Equipment1.71B2.7B3.05B3.11B1.6B1.72B1.9B2.09B2.38B2.97B
Fixed Asset Turnover1.05x1.04x0.93x0.97x1.26x1.22x1.21x1.25x1.23x1.06x
Goodwill2.13B2.68B2.75B2.4B2.09B2.11B2.2B2.22B2.23B2.26B
Intangible Assets59.58M83.31M87.35M88.99M68.83M68.53M70.14M76.04M73.28M70M
Long-Term Investments18.3M73.51M13M60.52M000008.8M
Other Non-Current Assets20.21M51.32M49.57M64.93M2.58B79.13M94.97M92.7M72.55M43.24M
Total Assets+4.29B6.02B6.42B6.17B6.88B6.5B4.77B4.99B5.36B5.96B
Asset Turnover0.42x0.47x0.44x0.49x0.29x0.32x0.49x0.52x0.55x0.53x
Asset Growth %0.93%0.41%0.07%-0.04%0.11%-0.06%-0.27%0.05%0.07%0.11%
Total Current Liabilities+290.2M342.87M377.39M416.38M463.58M1.31B404.86M388.33M885.78M577.92M
Accounts Payable91.34M80.03M102.3M117.74M90.26M87.81M98.58M104.72M156.13M232.7M
Days Payables Outstanding31.6217.6122.6224.1627.62367.4396.68381.4825.3734.78
Short-Term Debt45.36M34.8M34.83M34.11M43.68M153.48M18.59M21.25M29.22M76.82M
Deferred Revenue (Current)1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Liabilities64.99M93.63M108.86M111.89M148.69M744.61M00512.74M808K
Current Ratio1.02x1.25x1.25x1.08x1.17x1.93x1.22x1.30x0.67x1.00x
Quick Ratio1.00x1.23x1.24x1.07x1.16x1.93x1.21x1.29x0.67x0.99x
Cash Conversion Cycle18.724.2922.8315.4231.98-295.22-329.41-313.4829.0214.9
Total Non-Current Liabilities+2.31B3.51B3.47B3.42B3.91B3.29B1.78B1.7B1.59B2.19B
Long-Term Debt2.2B3.25B3.21B3.16B3.11B2.97B1.48B1.36B1.34B1.88B
Capital Lease Obligations000085.64M84.03M116.84M116.43M111.7M101.83M
Deferred Tax Liabilities23.94M78.52M80.33M80.37M22.82M50.02M74.37M92.59M1.93M83.95M
Other Non-Current Liabilities86.66M164.86M166.43M154.27M696.3M188.73M110.5M125.03M129.22M122.3M
Total Liabilities2.6B3.86B3.85B3.84B4.37B4.6B2.19B2.09B2.47B2.77B
Total Debt+2.24B3.29B3.24B3.19B3.26B3.26B1.64B1.53B1.51B2.09B
Net Debt2.23B3.23B3.17B3.14B3.16B2.88B1.5B1.43B1.41B2.01B
Debt / Equity1.32x1.50x1.25x1.35x1.30x1.71x0.63x0.53x0.52x0.65x
Debt / EBITDA5.83x5.67x5.58x5.59x4.35x7.45x3.14x2.61x2.36x3.10x
Net Debt / EBITDA5.80x5.57x5.46x5.50x4.21x6.59x2.89x2.45x2.21x2.99x
Interest Coverage3.01x2.45x2.49x2.23x3.53x-5.38x6.70x6.17x4.49x
Total Equity+1.7B2.19B2.6B2.36B2.51B1.9B2.58B2.9B2.89B3.19B
Equity Growth %0.93%0.29%0.19%-0.09%0.06%-0.24%0.36%0.12%-0%0.1%
Book Value per Share24.8325.4229.8127.0628.5321.4428.4531.6931.7534.66
Total Shareholders' Equity1.69B2.17B2.57B2.33B2.51B1.9B2.52B2.81B2.78B3.07B
Common Stock707K867K871K874K877K880K890K899K913K918K
Retained Earnings220.99M220.14M428.57M252.82M361.75M-310.39M-119.75M153.39M131.72M387.33M
Treasury Stock0000000000
Accumulated OCI-104.65M-549.57M-374.12M-462.38M-414.88M-371.37M0000
Minority Interest8.05M17.75M22.42M28.81M0065.39M88.26M105.69M117.12M

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+240.4M361.48M399.58M414.08M332.9M658.81M374.48M380.57M462.34M129.69M
Operating CF Margin %0.13%0.13%0.14%0.14%0.17%0.32%0.16%0.15%0.16%0.04%
Operating CF Growth %1.09%0.5%0.11%0.04%-0.2%0.98%-0.43%0.02%0.21%-0.72%
Net Income118.47M4.18M199.59M-175.49M110.12M140.26M195.56M280.03M-15.66M264.48M
Depreciation & Amortization63.55M135.1M143.01M158.83M164.04M95.26M106.72M117.77M132.35M149.59M
Stock-Based Compensation20.47M28.34M23.47M22M17.31M037.53M29.64M32.29M37.11M
Deferred Taxes36.62M28.65M31.37M-9.71M1.78M53.11M11.77M16.55M-93.98M67.71M
Other Non-Cash Items19.22M187.32M20.38M382.06M70.41M207.06M66.4M5.94M400.71M16.68M
Working Capital Changes-17.93M-22.11M-18.25M36.39M-30.76M163.12M-43.5M-69.35M6.63M-405.88M
Change in Receivables-24.95M-15.72M-28.57M-16.82M-19.06M15.34M2.45M-41.98M-39.01M-2.33M
Change in Inventory-1.06M-29.22M11.82M29.61M6.48M0-13.99M000
Change in Payables6.87M22.69M-10.11M26.05M-21.35M77.99M6.16M5.17M17.4M-420.89M
Cash from Investing+-884.47M-660.37M-336.53M-360.96M-201.14M-281.84M1.02B-305.83M-397.22M-736.48M
Capital Expenditures-276.05M-307.47M-274.18M-341.46M-284.68M-216.62M-244.81M-296.15M-424.13M-690.38M
CapEx % of Revenue0.15%0.11%0.1%0.11%0.14%0.1%0.11%0.11%0.14%0.22%
Acquisitions----------
Investments----------
Other Investing-33.65M-42.7M-44.16M-1.31M31.83M-56.97M-269.58M-174K27.26M7.46M
Cash from Financing+563.6M358.84M-60.07M-67.33M-61.63M-51.5M-1.64B-110.9M-62.7M583.02M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0000000000
Share Repurchases----------
Other Financing-41.77M646M-2.77M-2.27M-6.42M-7.13M5.58M2.69M-46.45M7.9M
Net Change in Cash----------
Free Cash Flow+-35.64M54.01M125.4M72.62M48.22M442.19M129.67M84.42M38.21M-560.69M
FCF Margin %-0.02%0.02%0.04%0.02%0.02%0.21%0.06%0.03%0.01%-0.18%
FCF Growth %-18.46%2.52%1.32%-0.42%-0.34%8.17%-0.71%-0.35%-0.55%-15.68%
FCF per Share-0.520.631.440.830.554.991.430.920.42-6.09
FCF Conversion (FCF/Net Income)2.01x58.84x2.00x-2.36x3.06x-0.98x1.96x1.39x-21.34x0.51x
Interest Paid87.03M161.15M159.1M175.2M173.24M093.67M65.69M80.75M113.4M
Taxes Paid6.91M15.48M10.29M6.14M31.91M079.3M86.19M66.4M28.15M

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)9.27%0.32%8.36%-7.09%4.48%-30.52%8.51%9.96%-0.75%8.41%
Return on Invested Capital (ROIC)8.28%7.15%5.87%5.49%8.89%-7.01%8.33%8.8%8.25%
Gross Margin41.24%40.97%41.8%40.96%40.6%95.83%96.08%96.16%23.31%22.57%
Net Margin6.66%0.22%7.05%-5.83%5.42%-32.16%8.24%10.46%-0.74%8.1%
Debt / Equity1.32x1.50x1.25x1.35x1.30x1.71x0.63x0.53x0.52x0.65x
Interest Coverage3.01x2.45x2.49x2.23x3.53x-5.38x6.70x6.17x4.49x
FCF Conversion2.01x58.84x2.00x-2.36x3.06x-0.98x1.96x1.39x-21.34x0.51x
Revenue Growth78.63%56.64%0.9%6.21%-33.33%4.06%10.74%12.79%12.2%7.69%

Revenue by Segment

2015201620172018201920202021202220232024
United States Facilities1.43B1.7B1.81B1.9B2.01B2.09B2.31B2.61B2.93B3.15B
United States Facilities Growth-19.09%6.55%5.24%5.44%4.06%10.74%12.79%12.20%7.69%
United Kingdom Facility360.7M1.11B1.03B1.11B1.1B-----
United Kingdom Facility Growth-207.84%-7.56%7.92%-0.78%-----
Corporate and Other7.59M2.03M--------
Corporate and Other Growth--73.28%--------

Frequently Asked Questions

Valuation & Price

Acadia Healthcare Company, Inc. (ACHC) has a price-to-earnings (P/E) ratio of 4.3x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Acadia Healthcare Company, Inc. (ACHC) reported $3.27B in revenue for fiscal year 2024. This represents a 1375% increase from $221.4M in 2011.

Acadia Healthcare Company, Inc. (ACHC) grew revenue by 7.7% over the past year. This is steady growth.

Yes, Acadia Healthcare Company, Inc. (ACHC) is profitable, generating $107.4M in net income for fiscal year 2024 (8.1% net margin).

Dividend & Returns

Acadia Healthcare Company, Inc. (ACHC) has a return on equity (ROE) of 8.4%. This is below average, suggesting room for improvement.

Acadia Healthcare Company, Inc. (ACHC) had negative free cash flow of $179.5M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.